Home > Financial Ratios > AARTI DRUGS

AARTI DRUGS
Core EBITDA Growth

    Back to All Ratios
AARTI DRUGS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for AARTI DRUGS
Please provide your vote to see the results

AARTI DRUGS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -5.634.24-9.38-22.7066.63

What is the latest Core EBITDA Growth ratio of AARTI DRUGS ?

The latest Core EBITDA Growth ratio of AARTI DRUGS is -5.63 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025-5.63
Mar20244.24
Mar2023-9.38
Mar2022-22.70
Mar202166.63

How is Core EBITDA Growth of AARTI DRUGS Trending?

Years Core EBITDA Growth % Change
Mar2025 -5.63
Negative
Mar2024 4.24
Positive
Mar2023 -9.38
Negative
Mar2022 -22.7
Negative
Mar2021 66.63 -

Other Financial Ratios of AARTI DRUGS


Compare Core EBITDA Growth ratio of peers of AARTI DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AARTI DRUGS ₹3,492.7 Cr -2.9% 2.4% -18.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,909.0 Cr -2.5% 1% 7.5% Stock Analytics
DIVIS LABORATORIES ₹173,930.0 Cr -3.1% 0.3% -1.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹147,181.0 Cr -4.9% 2.8% 37.8% Stock Analytics
CIPLA ₹112,353.0 Cr -1.6% 5.6% -5.7% Stock Analytics
DR REDDYS LABORATORIES ₹107,608.0 Cr -3.2% -3.1% 4.8% Stock Analytics


AARTI DRUGS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AARTI DRUGS

-2.9%

2.4%

-18.5%

SENSEX

-1.5%

-3.4%

-9.1%


You may also like the below Video Courses